BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 3:52:00 PM | Browse: 639 | Download: 709
Publication Name World Journal of Gastroenterology
Manuscript ID 5156
Country United States
Received
2013-08-18 11:08
Peer-Review Started
2013-08-19 14:42
To Make the First Decision
2013-09-16 20:26
Return for Revision
2013-09-17 14:53
Revised
2013-10-25 04:44
Second Decision
2013-11-01 17:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-03 11:53
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-10 21:48
Typeset the Manuscript
2014-04-30 08:08
Publish the Manuscript Online
2014-05-07 10:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Patient perceptions of stool DNA testing for pan-digestive cancer screening: A survey questionnaire
Manuscript Source Invited Manuscript
All Author List Dennis Yang, Shauna L Hillman, Ann M Harris, Pamela S Sinicrope, Mary E Devens and David A Ahlquist
Funding Agency and Grant Number
Funding Agency Grant Number
Oswald Foundation
Corresponding Author David A Ahlquist, MD, Professor of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, United States. ahlquist.david@mayo.edu
Key Words Stool-DNA testing; Colorectal cancer screening; Gastrointestinal cancer screening; Patient perceptions
Core Tip The value of stool DNA testing could be expanded beyond colorectal cancer screening by simultaneously targeting gastrointestinal cancers above the colon. Early data suggest technical feasibility for such pan-cancer detection. However, while multi-organ stool DNA testing (MUST) would seem intuitively to have broad appeal; patient perceptions have not been evaluated. In this exploratory study, we demonstrate that patients were interested in using MUST if it was available to them. The potential unique ability to detect multiple cancers was its most distinguishing and attractive feature. General population surveys are warranted to corroborate these early findings.
Publish Date 2014-05-07 10:10
Citation Yang D, Hillman SL, Harris AM, Sinicrope PS, Devens ME, Ahlquist DA. Patient perceptions of stool DNA testing for pan-digestive cancer screening: A survey questionnaire. World J Gastroenterol 2014; 20(17): 4972-4979
URL http://www.wjgnet.com/1007-9327/full/v20/i17/4972.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i17.4972
Full Article (PDF) WJG-20-4972.pdf
Full Article (Word) WJG-20-4972.doc
Manuscript File 5156-Review.docx
Answering Reviewers 5156-Answering reviewers.pdf
Copyright License Agreement 5156-Copyright assignment.pdf
Peer-review Report 5156-Peer review(s).pdf
Scientific Editor Work List 5156-Scientific editor work list.doc